Home Search

eoe - search results

If you're not happy with the results, please do another search
AIM_Palforzia_SnackSafely_Article_Holiday_imagesFamily

This Holiday Season, See the Potential Impact that Peanut Allergy Treatment Can Make

0
Did you know there’s a treatment option in addition to avoidance alone?
CHOP Dupilumab Study

CHOP Receives $2M Philanthropic Gift to Launch Food Allergy Study Using Dupilumab

0
"A successful clinical trial would open the possibility of food introduction to more than 3,500 CHOP patients with EoE."

Notebooks, check. Backpack, check. Peanut allergy treatment, check.

0
What if you could give your child a treatment option, in addition to practicing a strict peanut-free diet?
Tanya Ednan-Laperouse and Emma Turay

Two UK Allergy Moms Who Suffered Horrific Losses Demand an Allergy Czar. We Should...

2
We applaud the efforts of Ms Ednan-Laperouse and Ms Turay and believe their concept of a single person responsible for the health and safety of the allergic community should be adopted here in the US.
Palforzia Ad

How the First FDA-Approved Therapy for Peanut Allergy is Helping Families

0
What is PALFORZIA?  PALFORZIA is a treatment for people who are allergic to peanuts. PALFORZIA can help reduce the severity of allergic reactions, including anaphylaxis,...
Dupixent (dupilumab)

Dupixent (dupilumab) Study Shows Significant Improvement in Eosinophilic Esophagitis Signs and Symptoms

Phase 3 trial in (EoE) to show a significantly improved structural and histologic measures, while rapidly improving ability to swallow in patients 12 years and older
US Faster Act

The FASTER Act: What It Does and Why YOU Need to Help Pass It

0
FARE can't do it alone: Do your part to help pass the FASTER Act.
End Allergies Together

End Allergies Together, Responsible for Funding Important Research, is Winding Down Operations

"We are grateful to all of those who have supported us and helped E.A.T make such a significant impact on the food allergy industry."
AR101

Phase 3 Trial Data Demonstrates Consistent Safety and Efficacy of AR101 in Children and...

0
“Results of the European ARTEMIS trial provide further clinical validation of the safety and efficacy of AR101 for children and adolescents with peanut allergy.”
EoE

High-Tech Tissue Study Reveals Which Cells Drive a Painful Food Allergy

Findings from Cincinnati Children’s also raise questions about butyrate, a popular food supplement.